stride study semaglutide ACC 25 Late-Breaking Discussion: STRIDE: for Functional Capacity in Pts with T2D and PAD ACC 25: semaglutide improves PAD

By activating its cognate G protein-coupled receptor (GLP-1R) primarily on pancreatic -cells, GLP-1 stimulates glucose-dependent insulin release, leading to glucose uptake and improved glycemic control 26,27

These medications mimic the action of a hormone called glucagon-like peptide-1 (GLP-1), which increases insulin secretion, decreases glucagon release, and slows gastric emptying

Oral semaglutide, by contrast, must dissolve in your stomach and pass through your intestines for absorption, exposing it to stomach acid and digestive enzymes that can break down the compound

Yes, non-diabetics can take Ozempic for weight loss if prescribed by a doctor

Are taste changes from GLP-1 therapy permanent

Tirzepatide is a dual agonist targeting both GLP-1 and GIP receptors, improving insulin sensitivity and promoting fullness, leading to superior weight losssome patients lose over 20%, with an average of 15%